(Q31046838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Candesartan cilexetil in children with hypertension or proteinuria: preliminary data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Giacomo D Simonetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Rodo O von Vigier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Martin Konrad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mattia Rizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mario G Bianchetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

27 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

1480-1482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802178%20AND%20SRC:MED&resulttype=core&format=json

"Why do they do that?" The compliance conundrum

25 December 2019

cites work

1 reference

12 December 2020

Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders

1 reference

12 December 2020

A double-blind, dose-response study of losartan in hypertensive children

1 reference

12 December 2020

Lack of pediatric drug formulations

1 reference

12 December 2020

The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy

1 reference

12 December 2020

Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria

1 reference

12 December 2020

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

12 December 2020

Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

1 reference

12 December 2020

Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.

1 reference

12 December 2020

Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases

1 reference

12 December 2020

Angiotensin II receptor antagonist treatment during pregnancy

1 reference

12 December 2020

Dosage equivalents of AT1-receptor antagonists available in Germany

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises

1 reference

12 December 2020

Meta-analysis of large outcome trials of angiotensin receptor blockers in hypertension

1 reference

12 December 2020

Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease

1 reference

12 December 2020